Siddharth Srivastava

Dr. Siddharth Srivastava


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2021 in Indian Journal of Gastroenterology
Verified
Journal Article
Open access
PDF file
ADAmol S. Dahale
Amol S. Dahale
SSSiddharth Srivastava
Siddharth Srivastava
SSSundeep Singh Saluja
Sundeep Singh Saluja
SSSanjeev Sachdeva
Sanjeev Sachdeva
ADAshok Dalal
Ashok Dalal
SVShivakumar Varakanahalli
Shivakumar Varakanahalli
Background Scope-induced duodenal perforation is a life-threatening complication and surgery remains the standard of care. With the advent of over-the-scope clip (OTSC), scope-induced perforations are increasingly managed conservatively, though there is no study comparing this form of non-surgical treatment with surgery. We aimed to compare OTSC and surgery in the management of scope-induced perforation of the duodenum. Methods We retrospectively collected data of scope-induced duodenal perforation patients. Perforations identified and treated within 24 h of procedure were analyzed. Factors analyzed were spectrum, etiology, baseline parameters, perforation size, outcome, comorbidities, and duration of hospital stay. Results A total of 25 patients had type I duodenal perforations, out of whom five were excluded due to delayed diagnosis and treatment. Of the twenty, eight were treated with OTSC placement while the rest underwent surgery. Age was comparable and the majority were females. Baseline parameters and comorbidities were similar in both the groups. The median size of perforation was 1.5 cm in both the OTSC group and the surgical group. All patients were treated with standard of care according to institutional protocols. Patients in the OTSC group were started orally after 48 h of OTSC placement, while in the surgery group median time to oral intake was 7 days. Two patients in the surgical group died while there was no mortality in the OTSC group (p = 0.48). Median hospital stay was shorter in the OTSC group (2 days vs. 22 days, p = 0.003). Conclusions OTSC is a feasible and better option in type I duodenal perforations with a shorter hospital stay.

24 June 2023 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
BSBarjesh Chander Sharma
Barjesh Chander Sharma
SMSudhir Maharshi
Sudhir Maharshi
SSSanjeev Sachdeva
Sanjeev Sachdeva
BMBhawna Mahajan
Bhawna Mahajan
ASAshok Sharma
Ashok Sharma
USUjjwal Sonika
Ujjwal Sonika

23 January 2023 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
HAHardik Ahuja
Hardik Ahuja
BSBarjesh Chander Sharma
Barjesh Chander Sharma
SSSanjeev Sachdeva
Sanjeev Sachdeva
BMBhawna Mahajan
Bhawna Mahajan
ASAshok Sharma
Ashok Sharma
USUjjwal Sonika
Ujjwal Sonika

5 February 2023 in Cureus
Verified
Journal Article
Open access
PDF file
MKManish Kumar
Manish Kumar
USUjjwal Sonika
Ujjwal Sonika
SSSanjeev Sachdeva
Sanjeev Sachdeva
ADAshok Dalal
Ashok Dalal
PNPoonam Narang
Poonam Narang
SSSiddharth Srivastava
Siddharth Srivastava
Background and objectives Studies on the natural history of asymptomatic walled-off necrosis (WON) in acute pancreatitis (AP) are scarce. We conducted a prospective observational study to look for the incidence of infection in WON. Material and methods In this study, we included 30 consecutive AP patients with asymptomatic WON. Their baseline clinical, laboratory, and radiological parameters were recorded and followed up for three months. Mann Whitney U test and unpaired t-tests were used for quantitative data and chi-square and Fisher’s exact tests were used for qualitative data analysis. A p-value <0.05 was considered significant. Receiver operating characteristic curve (ROC) analysis was done to identify the appropriate cutoffs for the significant variables. Results Of the 30 patients enrolled, 25 (83.3%) were males. Alcohol was the most common etiology. Eight patients (26.6%) developed an infection on follow-up. All were managed by drainage either percutaneously (n=4, 50%) or endoscopically (n=3, 37.5%). One patient required both. No patient required surgery and there was no mortality. Median baseline C-reactive protein (CRP) was higher in infection group 76 (IQR=34.8) mg/L vs asymptomatic group, 9.5 mg/dl (IQR=13.6), p<0.001. IL-6 and tumor necrosis factor (TNF)-alpha was also higher in the infection group. The size of the largest collection (157.50±33.59 mm vs 81.95±26.22 mm, P<0.001) and CT severity index (CTSI) (9.50±0.93 vs 7.82±1.37, p<0.01) were also higher in infection group as compared to the asymptomatic group. ROC curve analysis of baseline CRP (cutoff 49.5mg/dl), size of WON (cutoff 127mm) and CTSI (cutoff of 9) showed AUROC (area under ROC) of 1, 0.97, and 0.81 respectively for the future development of infection in WON. Conclusion Around one-fourth of asymptomatic WON patients developed an infection during three-months follow-up. Most patients with infected WON can be managed conservatively.

3 August 2017 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
SSSiddharth Srivastava
Siddharth Srivastava
BSB. C. Sharma
B. C. Sharma
APA. S. Puri
A. S. Puri
SSS. Sachdeva
S. Sachdeva
LJL. Jain
L. Jain
AJA. Jindal
A. Jindal
Background and aims Perforation is one of the worst complications of therapeutic endoscopic retrograde cholangiopancreatography (ERCP). We aimed to study the epidemiology of ERCP related perforation and the impact of completion of intended procedure on the outcome of this complication. Methods ERCP records from January 2007 to April 2012 were independently evaluated by two investigators for the occurrence of procedure related perforations. A total of 11 500 patients underwent therapeutic ERCP during the study period. The case records of 171 (1.5 %) patients with ERCP related perforations were reviewed to analyze the epidemiology and risk factors associated with poor outcome. Results Of the 171 patients included in this study, the majority of perforations (n = 129, 75.4 %) were related to use of the needle-knife precut technique. Female gender (1.9 % vs 0.7 %, P < 0.001), age > 40 years (1.7 % vs 1.1 %, P < 0.01), and benign disease (1.7 % vs. 1.1 %, P < 0.01) were risk factors for ERCP related perforation. Most of the perforations (n = 135, 79 %) were detected during the procedure. The majority of patients were managed conservatively (n = 164, 96 %). Although 159 patients recovered, 12 patients (7 %) did not survive. Completion of intended biliary procedure for primary disease was associated with low risk of mortality (2 % vs 15.4 %, P < 0.001). Conclusions ERCP related perforation is uncommon. The majority of patients can be managed conservatively. The risk of mortality is low and completion of the intended biliary procedure decreases the risk of mortality.

26 December 2018 in International Journal of Surgical Pathology
Verified
Journal Article
Closed access
YNYashaswini Nallacheruvu
Yashaswini Nallacheruvu
KGKavita Gaur
Kavita Gaur
PSPuja Sakhuja
Puja Sakhuja
AAAnil Kumar Agarwal
Anil Kumar Agarwal
SSSiddharth Srivastava
Siddharth Srivastava
Mucoepidermoid carcinoma (MEC) is rarely reported in the hepatobiliary system. In this article, we detail the first case of MEC arising from the gallbladder, presenting in a 50-year-old male. Imaging and gross examination showed a large mass in the gallbladder fossa infiltrating the liver. This microscopically displayed the classical morphology of MEC, which was confirmed on dual immunostain for p63 and CK7 and histochemical staining for mucin. MUC and p53 immunoexpression patterns suggested a poor prognosis. The patient succumbed to the disease with liver metastasis within 6 months. The cytomorphology of the metastatic lesion is also presented. Differences in the stem cell niches in the gallbladder and the rest of the biliary tract may possibly indicate the reason for the rarity of this tumor in the gallbladder. A possibly aggressive biological behavior of the gallbladder MEC necessitates its distinction from entities like the adenosquamous carcinoma.